Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Major depressive disorder, antidepressants, and sexual dysfunction.

Anita H Clayton1, Angel L Montejo

  • 1Department of Psychiatric Medicine, University of Virginia Health System, Charlottesville, 22908, USA. ahc8v@virginia.edu

The Journal of Clinical Psychiatry
|July 20, 2006
PubMed
Summary

Sexual dysfunction is common, especially with antidepressant medications like SSRIs. Alternative antidepressants and antidotal therapies may effectively manage these side effects.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Initiating dextromethorphan-bupropion extended release in patients with major depressive disorder: Delphi panel expert consensus recommendations.

Current medical research and opinion·2026
Same author

Anhedonia in patients with major depressive disorder (MDD): State-of-the-art consensus review.

Psychiatry research·2026
Same author

The American Society of Clinical Psychopharmacology task force consensus statement on the deprescribing of stimulant medications in adults with ADHD<sup>✰</sup>.

European neuropsychopharmacology : the journal of the European College of Neuropsychopharmacology·2026
Same author

Improvement in Antipsychotic-Related Sexual Dysfunction After Switching to Cariprazine: A Prospective Real-World Study.

Journal of clinical medicine·2026
Same author

Examining recruitment differences by race, ethnicity, and age to a decentralized trial of an internet-delivered intervention for sexual health after breast cancer: the WF-2202 SHINE trial.

Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer·2026
Same author

Efficacy and Clinical Relevance of Adjunctive Cariprazine Treatment in Patients with Major Depressive Disorder: Post Hoc Analyses from a Phase III Study.

Neuropsychiatric disease and treatment·2026

Area of Science:

  • Psychiatry and Pharmacology

Background:

  • Sexual dysfunction is a prevalent issue, often linked to general medical conditions, psychiatric disorders, and medications.
  • Antidepressant medications, particularly Selective Serotonin Reuptake Inhibitors (SSRIs), are strongly associated with increased incidence of sexual dysfunction.
  • A significant percentage of patients (42%) experience suboptimal treatment for antidepressant-induced sexual dysfunction, often awaiting spontaneous remission.

Purpose of the Study:

  • To review the relationship between antidepressant mechanisms of action and sexual dysfunction.
  • To explore alternative antidepressant options and antidotal therapies for managing sexual dysfunction.
  • To highlight the need for further systematic investigation into effective management strategies.

Main Methods:

  • Review of existing literature on sexual dysfunction and antidepressant medications.

Related Experiment Videos

  • Analysis of studies comparing SSRIs with other antidepressants (bupropion, nefazodone, mirtazapine) regarding efficacy and sexual side effects.
  • Examination of management strategies, including drug substitution and antidotal therapy.

    • Main Results:

    • SSRIs demonstrate a higher incidence of sexual dysfunction compared to antidepressants with different mechanisms.
    • Bupropion, nefazodone, and mirtazapine show efficacy in treating depressive symptoms and alleviating sexual dysfunction.
    • Antidotal therapy is identified as an effective strategy, though systematic data is limited.

    Conclusions:

    • Antidepressant-induced sexual dysfunction is a significant clinical challenge.
    • Medications like bupropion, nefazodone, and mirtazapine offer alternatives to SSRIs with potentially fewer sexual side effects.
    • Further research is crucial to establish robust evidence for antidotal therapies in managing sexual dysfunction.